Room: 2xx We therefore analyzed the outcome in 120 HOCM patients (pts., mean age @ index i... Overview of diagnostic and therapeutic options in H(O)CM. Prof. Dirk Becker University Würzburg Biozentre, Julius-von-Sachs-Institute for Biosciences Department for Molecular Pflant-Pphysiologie and Biophysics - Botany I Julius-von-Sachs-Platz 2 97082 Wuerzburg Germany Tel. Prof. Dr. med. 2017 Feb;142(4):276-281. doi: 10.1055/s-0042-121855. Informationen zu den dort erfassten Daten und deren Verarbeitung finden Sie in deren Datenschutzerklärung. Prof. Dr. Julia Becker Professor of Social Psychology, University of Osnabrück. However, there is concern of a higher risk for ventricular tachyarrhythmias and sudden death due to the myocardial scar created after PTSMA. Eine Herzenssache: Hubert Seggewiß hält sein letztes Herz-Seminar. ... Mit 'OK' verlassen Sie die Seiten der Universität Würzburg und werden zu Facebook weitergeleitet. Er gibt an, stärkere „Schme... Alcohol septal ablation is an emerging technique for the reduction of the subaortic gradient in hypertrophic obstructive cardiomyopathy. Dtsch Med Wochenschr. Malte Meesmann Internist – Kardiologie - Hypertensiologe DHL - Spezielle Rhythmologie Tel. Dr. Seggewiß-Bernhardt Finden Sie mehr zu Priv.-Doz. Wählen Sie hier einen Stimmbezirk aus, um die Ergebnisse anzeigen zu lassen: Seit Februar 2016 ist er außerplanmäßiger Professor an der Universität Würzburg. Only verified researchers can join ResearchGate and send messages to other members. Samuel Kounev Dean of the Faculty of Mathematics and Computer Science Chairholder of the Chair of Software Engineering (Informatik II) Department of Computer Science University of Würzburg Informatics Building, Room A112 Am Hubland D-97074 Würzburg, Germany Phone:+49 (931) 31 82452 Fax. Historical perspectiveTechniqueIndications and contraindicationsResultsHOCM and concomitant cardiac diseaseComparison of PTSMA with myectomySummary. By clicking 'OK' you are leaving the web sites of the Julius-Maximilians-Universität Würzburg and will be redirected to Facebook. Technische Physik University of Würzburg Am Hubland. at risk for complete heart block (CHB) and subsequent pacemaker implantation. Sehen Sie sich das Profil von Prof. Dr.med. 2 / Haus D15 • D-97080 Würzburg Tel. Einer, der seit vielen Jahren die Erkrankung erforscht und behandelt, ist Prof. Dr. Hubert Seggewiß. E-Mail: sabine.segerer@uni-wuerzburg.de Seggewiß-Bernhardt Ruth (Privatdoz.Dr.) We analyzed data from the Carotid Artery Stent (CAS) Registry. JavaScript scheint in Ihrem Browser deaktiviert zu sein. Studies in Medicine at the University of Würzburg, dissertation at the Institute for Physiology with Prof. H. Oberleithner. Josef-Schneider-Str. nat. Sex-related differences in symptomatic patients with hypertrophic obstructive cardiomyopathy – Time for a new definition? Surgical myectomy in HOCM: Still gold standard for septal reduction? Recent registry analyses including the European multicenter registry (Euro-ASA) documented a favourable long-term outcome of septal ablation (ASA/PTSMA) competitive to surgical myectomy. The value of the side intervened upon has not been analyzed yet. Insbesondere bei jüngeren Patienten besteht ein erhöhtes Risiko eines plötzlichen Herztodes. Chefarzt Prof. Dr. med. Freiburg), associate professor in Würzburg (1993-1999), full professor in Siegen … Objective We present a c... Data on the safety of carotid artery stenting (CAS) in a large number of unselected patients with contralateral occlusion and significant ipsilateral stenosis are less known. Seit Februar 2016 ist er außerplanmäßiger Professor an der Universität Würzburg. : +49 (0)931 31 86822. office: 5.E.13 office hours: Please contact via e-mail. We are the first federally funded institution worldwide to … Semester. An die 100 Eingriffe hat er pro Jahr in Schweinfurt gemacht. Die allgemein bekannten und traditionsreichen Namen der beiden Standorte bleiben erhalten. The KiLi project is a German Science Foundation funded research unit (DFG research unit … Universitätsklinikum Würzburg Deutsches Zentrum für Herzinsuffizienz (DZHI) Comprehensive Heart Failure Center (CHFC) Am Schwarzenberg 15, Haus A15 97078 Würzburg. We report long-term o... Hypertrophic obstructive cardiomyopathy is the most common genetic cardiac disease and is generally characterised by asymmetric septal hypertrophy and intraventricular obstruction. Jedes Jahr kommen etwa 60 Patienten aus aller Welt für diesen Eingriff ans Juliusspital, oft auch schon mit … Institut für Organische Chemie & Center for Nanosystems Chemistry (CNC) Am Hubland 97074 Würzburg, Germany. Sie müssen JavaScript in Ihrem Browser aktivieren um alle Funktionen der Seite nutzen zu können. The aim of this study was to describe the safety and outcomes of alcohol septal ablation (ASA) in younger patients with obstructive hypertrophic cardiomyopathy. Hubert Seggewiß auf PubMed.gov, Lebenslauf von Prof. Dr. Hubert Seggewiß herunterladen, Öffnungszeiten der Herzinsuffizienz-Ambulanz, Herzinsuffizienz-Ambulanz+49 931 201-46301, Deutsches Zentrum für Herzinsuffizienz Würzburg | Universitätsklinikum Würzburg | Am Schwarzenberg 15 | Haus A15 | 97078 Würzburg | Deutschland, Anstalt des öffentlichen RechtsJosef-Schneider-Straße 297080 WürzburgTelefon: +49 931 201-0, Zentrum für Seltene Erkrankungen (ZESE Nordbayern), Wissenschaftliche Institute der Medizinischen Fakultät, Wissenschaftliche Einrichtungen des Universitätsklinikums, Ausbildung / Schulzentrum für Gesundheitsberufe, Fort- und Weiterbildung Ärztinnen und Ärzte, Aktuelle informationen zu Bauprojekten am UKW, Internistische Intensiv- und Notfallmedizin, Mund-, Kiefer- und Plastische Gesichtschirurgie, ZMKG (Zentrum für Zahn-, Mund- und Kiefergesundheit), Comprehensive Cancer Center Mainfranken (CCC MF), Deutsches Zentrum für Herzinsuffizienz (DZHI), Interdisziplinäre Biomaterial- und Datenbank (ibdw), Interdisziplinäres Zentrum für Klinische Forschung (IZKF), Muskuloskelettales Centrum Würzburg (MCW), Zentrale für Klinische Studien am Universitätsklinikum Würzburg (ZKSW), Zentrum für Experimentelle Molekulare Medizin (ZEMM), Rudolf-Virchow-Zentrum – Center for Integrative and Translational Bioimaging, Zentrum für vorsprachliche Entwicklung und Entwicklungsstörungen (ZVES), Frühdiagnosezentrum / Sozialpädiatrisches Zentrum, Interdisziplinäres Thoraxzentrum Mainfranken (iTZM), Interdisziplinäres Zentrum für Angsterkrankungen (IZA), Interdisziplinäres Zentrum für Lippen-Kiefer-Gaumen-Segelspalten, Interdisziplinäres Zentrum für Palliativmedizin, Interdisziplinäres Zentrum für Stimme und Schlucken (IZSS), Stammzelltransplantationszentrum (Erwachsene/Kinder), WHO REMPAN Kollaborationszentrum Würzburg, Zentrum für Interdisziplinäre Schmerzmedizin, Christiane Herzog-Zentrum für Mukoviszidose Unterfranken, FAZiT Fabry Zentrum für interdisziplinäre Therapie Würzburg, Würzburger Zentrum für Neurofibromatosen (WZNF), Zentrum für Achalasie und andere Ösophagusmotilitätsstörungen, Zentrum für blasenbildende Autoimmundermatosen, Zentrum für Primäre Immundefekte Nordbayern (ZIN), Zentrum für seltene neuromuskuläre Erkrankungen, Transregionales Netzwerk für Schlaganfallintervention mit Telemedizin (TRANSIT Stroke), Frauenbeauftragte der Medizinischen Fakultät, Staatliches Berufliches Schulzentrum für Gesundheitsberufe, Institut für Klinische Epidemiologie und Biometrie, IMIB - Institut für Molekulare Infektionsbiologie, Institut für Pharmakologie und Toxikologie, Abteilung für Medizinische Psychologie und Psychotherapie, Medizinische Soziologie und Rehabilitationswissenschaften, Institut für Medizinische Strahlenkunde und Zellforschung, Institut für Medizinische Lehre und Ausbildungsforschung, Lehrstuhl für Tissue Engineering und Regenerative Medizin, Lehrstuhl für experimentelle Biomedizin I, Lehrstuhl für experimentelle Biomedizin II, Lehrstuhl für Funktionswerkstoffe der Medizin und der Zahnheilkunde, Lehrstuhl für Molekulare und Zelluläre Bildgebung, Rudolf-Virchow-Zentrum für experimentelle Biomedizin (RVZ), Sonderforschungsbereiche, Transregios und Forschergruppen, Leopoldina-Krankenhaus der Stadt Schweinfurt, Kaufmännische Berufe und Berufe rund um Medizin und Zahnmedizin, Ausbildungen im Handwerk und in der Informatik, Medizin und Wissenschaft auf höchstem Niveau, Preisträger und herausragende Persönlichkeiten, Die Stabsstellen des Vorstands auf einen Blick, Betriebliche Sozial- und Konfliktberatung, Stabsstelle Datenschutz, Compliance und Organisation, Stabsstelle Servicezentrum Medizin-Informatik (SMI), Beauftragte, Kommissionen und Arbeitsgruppen, Geschäftsbereich 1: Forschungsförderung und Drittmittelmanagement, Geschäftsbereich 3: Finanzen und Controlling, Geschäftsbereich 4: Wirtschaft und Versorgung, Amtliche Veröffentlichungen und Satzungen, Aktuelle Informationen zu Bauprojekten am UKW. Prof. Dr. Anke Hoeffler I am a Professor of Development Research at the Department of Politics & Public Administration at the University of Konstanz. 12/2001: Promotion zum Dr. med. Therefore, we analyzed baseline characteristics of symptomatic patients with indication for alcohol septal ablation (PTSMA) with respect to gender. Their current project is 'Catheter-based Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Long-term Follow-Up 1996-2016. Im Januar 2017 haben sich Juliusspital Krankenhaus und Missioklinik zum KWM zusammengeschlossen. 70 % der betroffenen Patienten ist eine dynamische (Ausflussbahn-)Obstruktion des linken Ventrikels. Does p.Q247X in TRIM63 cause human hypertrophic cardiomyopathy? With the retirement of Prof. Rapp the MSZ has seen a major change, which touched the scientific direction of the Institute as a whole. patients: up to 10% of the patients develop a complete heart... Optimal therapy of hypertrophic cardiomyopathy, The paper in german language is out now: Therefore, this position paper focuse... Background: We now report on the mid-term course (3-6 months) of 242 pts... Introduction Objectives: Geschäftsstelle +49 931 201-46333 [Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy ]. Auf LinkedIn können Sie sich das vollständige Profil ansehen und mehr über die Kontakte von Prof. Dr.med. Its prevalence is 0.2% to 0.6%. Aims: © 2008-2021 ResearchGate GmbH. Head of Department: Prof. Dr. Jürgen Groll Pleicherwall 2, D-97070 Würzburg | Tel: +49 (0) 931 201-73610 | E: office@fmz.uni-wuerzburg.de https://www.ncbi.nlm.nih.gov/pubmed/28235228. Englische Fachdidaktik Lehrstuhlinhaberin. Echocardiographic monitoring of the procedure with injection of echo-contrast agent in the balloon-occluded target... To the editor: On October 24, 2002, an article about septal ablation with alcohol for hypertrophic cardiomyopathy was published in the Journal.1 The majority of those named as authors of the article did not have an opportunity to review and verify the data and to approve the manuscript. Wir fühlen uns jedem Patienten und für jede individuelle Behandlung persönlich verantwortlich: Von der Aufnahme unserer Patienten über deren Diagnostik und Operation, einschließlich der Funktionsuntersuchungen und intensivstationären Betreuung, bis zur möglichst zeitnahen … Although the outcomes of single-centre and national ASA registries have been published, the long-term survival and clinical outcome of the procedure are still debated. Klaus Schilling. Cardiac tamponade is a condition caused by the compression of the heart due to slow or rapid accumulation of fluid (exudate), pus, blood, clots, or gas within the p... Variants in TRIM63, including a nonsense mutation (p.Q247X), have been suggested recently to cause hypertrophic cardiomyopathy. To verify pathogenicity of TRIM63 p.Q247X detected by whole-exome sequencing in a symptomless professional sports player seeking medical advice because of a prolonged QT interval found during a routine check-up. Research Interests. Patients with hypertrophic cardiomyopathy (HCM) exhibit a variable phenotype with ventricular hypertrophy as the cardinal manifestation and left ventricular (LV) outflow tract obstruction (LVOTO) as a key pathophysiologic determinant. Development of apical aneurysm in apical HCM. Informatics VII : Robotics and Telematics Informatics building, room B100 Julius-Maximilians-University Würzburg Am Hubland D-97074 Würzburg Germany Tel. Methods and results: In the first 39 pts. : Results From the Carotid Artery Stent (CAS)-Registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK), Assessment of myocardial scarring by contrast enhanced magnetic resonance imaging in a patient 11 years after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy, Left ventricular outflow tract obstruction in patient with hypertrophic cardiomyopathy: increase in gradient after dynamic exercise. The "Institut für Medizinische Strahlenkunde und Zellforschung" (MSZ) was founded in 1993 and adjusted to modern safety standards by extensive remedial actions, which were completed in 2006. 1991-1992. Initiatoren sind Mezis, NeurologyFirst und Transparency Deutschland. Data privacy protection. Prof. Dr. Heike Walles. Between 1996 and December 2009, 5,535 pr... To compare characteristics and outcome of patients with re-stenoses after prior carotid artery stenting (CAS) treated with repeat carotid interventions (Re-CI) with CAS for de novo lesions. In June 2018 I was offered an Alexander von Humboldt Professorship, Germany’s most valuable international research award. Prof. Dr. Ulrike Holzgrabe (Chairperson) Chairperson of Pharmaceutical and Medicinal Chemistry Institute of Pharmacy & Food Chemistry University of Würzburg. HCM patients show an increased risk of sudden cardiac deaths especially in younger patients. Hubert Seggewiß an, der die Klinik mehr als 17 Jahre geleitet hat und nunmehr in den wohlverdienten Ruhestand ging. Room 204. The HCM Risk-SCD model for prediction of sudden cardiac death (SCD) in hypertrophic cardiomyopathy recommended by the 2014 European Society of Cardiology (ESC) guidelines has not been validated after septal reduction therapy. True to its motto ‘Science for Society’, JMU is committed to advancing … The aim of this study was to analyze hemodynamic and clinical outcome in a cohort of 312 patients who were followed up over a period of 12 months after alcohol septal ablation (PTSMA) for symptomatic hypertrophic obstructive cardiomyopathy (HOCM). Juli der neue Chefarzt der Medizinischen Klinik 1 im Leopoldina-Krankenhaus Schweinfurt. - Ihr Leopoldina-Team Welcome to the Würzburg-based Helmholtz-Institute for RNA-based Infection Research (HIRI). The aim of this study was to evaluate the short- and long-term outcomes in ASA patients with mild hypertrophy (IVS ≤ 16 mm). Freiburg), Diplôme de Langue et Civilisation Francaise (Sorbonne, Paris), Dr. rer. Als modernes Schwerpunkt-Krankenhaus der Region ist es unser Anspruch, Spitzenmedizin mit anteilnehmender Versorgung zu verbinden - an 365 Tagen im Jahr, 24 Stunden am Tag. Germany. We analyzed data from the Carotid Artery Stent (CAS)-Registry. - Lehrstuhlinhaber Zimmer 495. The aim of this study was to evaluate the safety and efficacy of ASA ac... Hypertrophic cardiomyopathy is the most common genetically caused cardiac disease. Percutaneous septal ablation after unsuccessful surgical myectomy for patients with hypertrophic obstructive cardiomyopathy, Langzeitverlauf nach perkutaner Septumablation bei hypertropher obstruktiver Kardiomyopathie, Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy, One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: Predictors of hemodynamic and clinical response. Is alcohol septal ablation in women performed too late? Wesentliches pathophysiologisches Zeichen bei ca. Dr. med. AiP at the Institute for Hygiene and Microbiology, University of Würzburg; Dr. med. Prof. Dr. Julia Becker. Prof. Dr. Hubert Seggewiß. Registry results of the new catheter-based method in the treatment for HOCM are missing so far. Synkopen und Prä... Background: Christoph Maack, Facharzt für Innere Medizin u. Kardiologie „Gibt es Neues in Diagnose und Therapie der HCM/HOCM?“ Prof. Dr. med. Prof. Dr. Hubert Seggewiß Mitbegründer von DOCTOR HEART MUSIC Dr. Kornelia und Prof. Dr. Hubert Seggewiß – eine Internistin und ein Kardiologe mit einem ausgesprochenen Faible für gute handgemachte Musik. (LVOT) and reduction of LVOT gradients. Hypertrophic cardiomyopathy is the most common genetically determined cardiac disease with a prevalence of 0.2–0.6%. : … who underwent PTSMA in 1996,... Percutaneous septal ablation (PTSMA) in hypertrophic obstructive cardiomyopathy (HOCM) aims to The first cases of alcohol septal ablation (ASA) for obstructive hypertrophic cardiomyopathy (HCM) were published two decades ago. E-Mail: hubert.seggewiss@hocm.de +49-931-31-87067 Fax +49-931-31-86679 A position statement from the ESC Working Group on Myocardial and Pericardial Diseases, Myocardial contrast echocardiography guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy with a new echocardiographic contrast agent, The role of endovascular expertise in carotid artery stenting: results from the ALKK-CAS-Registry in 5,535 patients, Alcohol septal ablation for hypertrophic obstructive cardiomyopathy, Carotid artery interventions for restenosis after prior stenting: Is it different from interventions of de novo lesions? The Software Engineering Group, also called Descartes Group, is headed by Prof. Dr. Samuel Kounev and focuses on a range of topics related to the engineering of software for building dependable and efficient distributed systems, such as cloud-based systems, cyber-physical systems, and Internet-of-Things (IoT) applications. In 2008, The ESC Working Group on Myocardial and Pericardial Diseases proposed an updated classification of cardiomyopathies based on morphological and functional phenotypes and subcategories of familial/genetic and non-familial/non-genetic disease. All patients entered in... Percutaneous alcohol septal ablation (PTSMA) is an established treatment for symptomatic patients (pts) with hypertrophic obstructive cardiomyopathy (HOCM). Results from the carotid artery stent (CAS)-registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK), A Decade of Percutaneous Septal Ablation in Hypertrophic Cardiomyopathy, Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, Percutaneous transluminal septal myocardial ablation (PTSMA) of hypertrophic cardiomyopathy: Indonesian initial experience, LONG-TERM OUTCOME OF PERCUTANEOUS SEPTAL ABLATION FOR SYMPTOMATIC HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY, NSTEMI als Differenzialdiagnose beim Thoraxtrauma, Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy, Optimal branch selection in alcohol septal ablation, Effectiveness and Safety of Carotid Artery Stenting for Significant Carotid Stenosis in Patients With Contralateral Occlusion (from the German ALKK-CAS Registry Experience), Hypertrophic cardiomyopathy as a cause of sudden death, Carotid Artery Stenting: Do Procedural Complications Relate to the Side Intervened Upon? A total of 3,165 CAS procedures, 1,613 (51%) at the... We report on a 60 year-old male who was one of the first patients who underwent percutaneous transluminal septal myocardial ablation (PTSMA) in our institution in 1996. Prof. Dr. Marc Erich Latoschik Human-Computer Interaction Universität Würzburg Am Hubland D-97074 Würzburg +49 (0) 931 31 85871 ed.grubzreuw-inu04%kihcsotal.cram ⌂ Room 1.021, Building M1, Hubland South Consultation-Hour by appointment PGP Key Fingerprint 08 4E 7A 2B 8E 9C FE 5E 78 A5 EA 01 67 6C 36 23 The current guidelines suggest alcohol septal ablation (ASA) is less effective in hypertrophic obstructive cardiomyopathy (HOCM) patients with severe left ventricular hypertrophy, despite acknowledging that systematic data are lacking. Diese und viele weitere Fragen erläutert Prof. Dr. Hubert Seggewiß, Medizinische Klinik – Kardiologie & Internistische Intensivmedizin am Juliusspital, zum Thema Bluthochdruck. In 1997, the Transcoronary Ablation of Septal Hypertrophy Registry (TASH Registry) was established by the German Cardiac Society (GCS) as a multicenter, national registry of patients with HOCM undergoing the new catheter interventional thera... Hypertrophic cardiomyopathy (HCM) is an inherited cardiac disease characterized by unexplained left ventricular hypertrophy, typically involving the interventricular septum. Tel. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 Years of experience, 436 Markers of diastolic function are the best correlates of NYHA class improvement after septal ablation for hypertrophic obstructive cardiomyopathy, 302 Long-term outcome of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy, An analysis of patients with hypertrophic obstructive cardiomyopathy and persisting New York Heart Association class III symptoms during long-term follow-up after septal ablation, Katheterbehandlung der hypertropisch obstruktiven Kardiomyopathie: Erste Analyse des Krankenhausverlaufes des Deutschen TASH-Registers, Catheter-based therapy for hypertrophic obstructive cardiomyopathy. From 01/ 2000 to 06/2005... To provide tools for predicting the course of AV conduction disturbances after ethanol-induced septal ablation (PTSMA) for hypertrophic obstructive cardiomyopathy (HOCM). Leopoldina-Krankenhaus Schweinfurt Gustav-Adolf-Straße 6-8 97422 Schweinfurt Telefon 09721 720-0 Telefax 09721 720-2975 www.leopoldina.de Kontaktformular Percutaneous alcohol septal ablation (PTSMA) is an established treatment for symptomatic patients with hypertrophic obstructive cardiomyopathy (HOCM). Synergien nutzen Methods and results: Die hypertrophe Kardiomyopathie ist die haufigste genetisch bedingte kardiale Erkrankung. It is frequently accompanied by dynamic left ventricular outflow tract obstruction and symptoms of dyspnea, angina, and syncope. January 2021 Jörg Vogel, again honoured as "highly cited researcher" News. Wolfgang Zöller, Patientenbeauftragter der Bundesregierung PP 03 10:15 - 10:55 Psychoonkologie Dr. Jochen Hefner, Würzburg 10:55 - 11:20 Kaffeepause PP 04 11:20 - 12:00 Studien PD Dr. Ruth Seggewiss, Würzburg 12:00 - 13:30 Mittagspause Clinical symptoms (e.g. Alcohol-induced infarction for treatment of symptomatic hypertrophic obstructive cardiomyopathy (HOCM) was discussed as a risk factor for increased cardiac mortality during follow-up. Die Video-Vorträge der DGIM-Kongresse stehen nur approbierten Ärztinnen und Ärzten in voller Länge kostenlos zur Verfügung. 9, 97078 Würzburg Tel. W... Cardiomyopathies are a heterogeneous group of heart muscle diseases and an important cause of heart failure (HF). Current knowledge on incidence, pathophysiology and natural history of HF in cardiomyopathies is limited, and distinct features of their therapeutic responses have not been systematically addressed. Patient outcome, quality of life as well as health care costs differ between patients with minor versus major stroke during carotid artery stenting. PTSMA by alcohol injection into septal branches has shown good acute and short-term results in symptomatic patients with hypertrophic obstructive cardiomyopathy. In the past decade, the availability of this sophisticated technique has revived the interest of cardiologists in left ventricular outflow tract obstruction, which led to the recognition that most patien... Advances in molecular genetics present new opportunities and challenges for cardiologists who manage patients and families with cardiomyopathies. Guiding of Percutaneous Transcoronary Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy by Myocardial Contrast Echocardiography: Carotid artery stenting in octogenarians: Results from the ALKK Carotid Artery Stent (CAS) Registry, 843 Septal ablation for hypertrophic obstructive cardiomyopathy: predictors of mid-term (12 months) success, Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Collateral vessel communication between septal branches. A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Prof. Dr. Michael SCHMITTEL b. Aim Percutaneous transluminal septal myocardial ablation (PTSMA), a non-surgical intervention to treat hypertrophic cardiomyopathy (HCM), has been a standard treatment in developed countries. Prof. Dr. rer. Medizin im Juliusspital. Evaluation of predictors for both subtypes of strokes is of paramount importance. Methods and results: : ++49 931-31-88007 Fax: ++49 931-31-46445 Mail: okurzai(at)hygiene.uni-wuerzburg.de. Methods and results This morning, Professor Hubert Seggewiss (Juliusspital Klinikum Würzburg Mitte, Würzburg, Germany) will guide delegates through a case of alcohol septal ablation of hypertrophic cardiomyopathy, recorded live from Klinikum Würzburg Mitte – Standort Juliusspital, Würzburg, Germany. Anatomic and technical aspects may influence the results of CAS. Peter Schneider sind 2 Jobs angegeben. Webseite ansehen Ostergruß von Oberbürgermeister Seggewiß: Stadt Weiden in … Predictors of minor versus major stroke during carotid artery stenting: Results from the carotid artery stenting (CAS) registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK), Survival after alcohol septal ablation in hypertrophic obstructive cardiomyopathy: results from a consecutive patient cohort, Clandestine subaortic stenosis as a cause of left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy, Ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy, Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, Alcohol septal ablation for recurrent left ventricular outflow tract obstruction after combined myectomy and mitral valve repair in hypertrophic cardiomyopathy, Serial septal branch assessment in hypertrophic obstructive cardiomyopathy New echocardiographic contrast agent for alcohol septal ablation, Diagnostic work-up in cardiomyopathies: Bridging the gap between clinical phenotypes and final diagnosis. Die hypertrophe Kardiomyopathie ist die häufigste genetisch bedingte kardiale Erkrankung. Wesentliches pathophysiologisches Zeichen bei ca. Sorry, you need to be a researcher to join ResearchGate. The aim of this study was to validate the HCM Risk-SCD model in patients undergoing alcohol septal ablation (ASA) and t... Hypertrophic cardiomyopathy is a genetic disorder characterized by marked hypertrophy of the myocardium. Prompt recognition of cardiac tamponade is critical since the underlying haemodynamic disorder can lead to death if not resolved by percutaneous or surgical drainage of the pericardium. This case series aim to study feasibility, safety and efficacy of PTSMA in National Car... Zeitdruck und unterschiedliche klinische Manifestationsformen einer akuten Erkrankung erschweren häufig das Erkennen der korrekten Diagnose.

Jugend Musiziert Bundeswettbewerb, Luigi's Mansion 4 Deutsch, Widerspruch Gegen Einen Strafzettel Der Privaten Parkplatzkontrolle Pdf, Partyboot Mieten Nrw, Wann Ist Man Ein Stiefkind, Fritzbox 6591 Artikelnummer, R4 Software Installieren Deutsch, Santorini Achim Speisekarte,